These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37746765)

  • 1. A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet.
    DiFrancesco JC; Ragona F; Murano C; Frosio A; Melgari D; Binda A; Calamaio S; Prevostini R; Mauri M; Canafoglia L; Castellotti B; Messina G; Gellera C; Previtali R; Veggiotti P; Milanesi R; Barbuti A; Solazzi R; Freri E; Granata T; Rivolta I
    Epilepsia; 2023 Dec; 64(12):e222-e228. PubMed ID: 37746765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability.
    Bonzanni M; DiFrancesco JC; Milanesi R; Campostrini G; Castellotti B; Bucchi A; Baruscotti M; Ferrarese C; Franceschetti S; Canafoglia L; Ragona F; Freri E; Labate A; Gambardella A; Costa C; Rivolta I; Gellera C; Granata T; Barbuti A; DiFrancesco D
    Neurobiol Dis; 2018 Oct; 118():55-63. PubMed ID: 29936235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the hyperpolarization-activated cyclic nucleotide-gated channels HCN1 and HCN2 in idiopathic generalized epilepsy.
    Tang B; Sander T; Craven KB; Hempelmann A; Escayg A
    Neurobiol Dis; 2008 Jan; 29(1):59-70. PubMed ID: 17931874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.
    Wu SZ; Ye H; Yang XG; Lu ZL; Qu Q; Qu J
    Clin Exp Pharmacol Physiol; 2018 Mar; 45(3):226-233. PubMed ID: 29047147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide.
    Chen S; Wang J; Siegelbaum SA
    J Gen Physiol; 2001 May; 117(5):491-504. PubMed ID: 11331358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy.
    Bleakley LE; McKenzie CE; Soh MS; Forster IC; Pinares-Garcia P; Sedo A; Kathirvel A; Churilov L; Jancovski N; Maljevic S; Berkovic SF; Scheffer IE; Petrou S; Santoro B; Reid CA
    Brain; 2021 Aug; 144(7):2060-2073. PubMed ID: 33822003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy.
    DiFrancesco JC; Barbuti A; Milanesi R; Coco S; Bucchi A; Bottelli G; Ferrarese C; Franceschetti S; Terragni B; Baruscotti M; DiFrancesco D
    J Neurosci; 2011 Nov; 31(48):17327-37. PubMed ID: 22131395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis and subcellular distribution of mRNA and protein expression of the hyperpolarization-activated cyclic nucleotide-gated channels throughout development in rat hippocampus.
    Brewster AL; Chen Y; Bender RA; Yeh A; Shigemoto R; Baram TZ
    Cereb Cortex; 2007 Mar; 17(3):702-12. PubMed ID: 16648453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCN Channel Phosphorylation Sites Mapped by Mass Spectrometry in Human Epilepsy Patients and in an Animal Model of Temporal Lobe Epilepsy.
    Concepcion FA; Khan MN; Ju Wang JD; Wei AD; Ojemann JG; Ko AL; Shi Y; Eng JK; Ramirez JM; Poolos NP
    Neuroscience; 2021 Apr; 460():13-30. PubMed ID: 33571596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of hyperpolarization-activated cyclic nucleotide-gated channels (HCN) in the hippocampus of patients with medial temporal lobe epilepsy and hippocampal sclerosis (MTLE-HS).
    Lin W; Qin J; Ni G; Li Y; Xie H; Yu J; Li H; Sui L; Guo Q; Fang Z; Zhou L
    Hippocampus; 2020 Oct; 30(10):1112-1126. PubMed ID: 32543742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in vitro inflammation model at molecular level.
    Civil Ürkmez Y; Avcı B; Günaydın C; Çelik ZB; Ürkmez SS
    Mol Cell Biochem; 2024 May; 479(5):1223-1229. PubMed ID: 37432633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-glycosylation on hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
    Li M; Tonggu L; Tang L; Wang L
    Biochem J; 2015 Feb; 466(1):77-84. PubMed ID: 25423599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Xylazine Produced Analgesic Effect via Inhibits Hyperpolarization-activated Cyclic Nucleotide-gated Ion Channels Currents].
    Chen FF; Li L; Chen XD; Zhou C; Liao DQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):20-26. PubMed ID: 31037900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality.
    Zhao X; Bucchi A; Oren RV; Kryukova Y; Dun W; Clancy CE; Robinson RB
    J Physiol; 2009 Apr; 587(Pt 7):1513-25. PubMed ID: 19171659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCN1 and HCN2 in Rat DRG neurons: levels in nociceptors and non-nociceptors, NT3-dependence and influence of CFA-induced skin inflammation on HCN2 and NT3 expression.
    Acosta C; McMullan S; Djouhri L; Gao L; Watkins R; Berry C; Dempsey K; Lawson SN
    PLoS One; 2012; 7(12):e50442. PubMed ID: 23236374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures.
    Brewster AL; Bernard JA; Gall CM; Baram TZ
    Neurobiol Dis; 2005; 19(1-2):200-7. PubMed ID: 15837575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional analysis of hyperpolarisation-activated nucleotide-gated (HCN) channels in the enteric nervous system.
    Xiao J; Nguyen TV; Ngui K; Strijbos PJ; Selmer IS; Neylon CB; Furness JB
    Neuroscience; 2004; 129(3):603-14. PubMed ID: 15541882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCN1 and HCN2 proteins are expressed in cochlear hair cells: HCN1 can form a ternary complex with protocadherin 15 CD3 and F-actin-binding filamin A or can interact with HCN2.
    Ramakrishnan NA; Drescher MJ; Khan KM; Hatfield JS; Drescher DG
    J Biol Chem; 2012 Nov; 287(45):37628-46. PubMed ID: 22948144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide selectively suppresses IH currents mediated by HCN1-containing channels.
    Kopp-Scheinpflug C; Pigott BM; Forsythe ID
    J Physiol; 2015 Apr; 593(7):1685-700. PubMed ID: 25605440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.